Ignite Creation Date:
2024-05-06 @ 8:11 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06282978
Status:
RECRUITING
Last Update Posted:
2024-03-06
First Post:
2023-11-23
Brief Title:
Study of Elranatamab for Relapsed or Refractory Myeloma in Patients Previously Exposed to Three-drug Classes
Sponsor:
PETHEMA Foundation
Organization:
PETHEMA Foundation
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-11-23
Start Date Type:
ACTUAL
Primary Completion Date:
2025-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-12
Completion Date Type:
ESTIMATED
First Submit Date:
2023-11-23
First Submit QC Date:
February 20 2024
Study First Post Date:
2024-02-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-04
Last Update Post Date:
2024-03-06
Last Update Post Date Type:
ACTUAL